NCT01302379View on ClinicalTrials.gov

Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Breast Neoplasms
Interventions
DRUG

Metformin

Week 1: 500 mg at dinner time Weeks 2-4: 1000 mg at dinner time Weeks 5+: 500 mg in morning; 1000 mg at dinner time

DRUG

Placebo

Week 1: 1 pill at dinner time Weeks 2-4: 2 pills at dinner time Weeks 5+: 1 pill in morning; 2 pills at dinner time

BEHAVIORAL

Lifestyle intervention

Telephone-based lifestyle intervention (dietary change and physical activity) for weight loss.

BEHAVIORAL

Standard printed dietary guidelines

Set of standard health education materials provided to participants at single time point (immediately after randomization)

Trial Locations (1)

92093

Moores UCSD Cancer Center, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT01302379 - Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors | Biotech Hunter | Biotech Hunter